Management of antimalarial-refractory cutaneous lupus erythematosus

Black AA , McCauliffe DP , Sontheimer RD Prevalence of acne rosacea in a Rheumatic-Skin disease subspecialty clinic . Lupus 1992; 1: 229-237.

Almeida L. , Grossman M. Widespread dermatophyte infections that mimic collagen-vascular disease. JAm Acad Dermatol 1990; 23: 955-857.

Feldmann R. , Salomon D. , Saurat J-H. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 1994; 189: 425-427.

Lipsker D. et al. Chloroquine-quinacrine association in resistant cutaneous lupus . Dermatology 1995; 190: 257-258.

Callen JP , Spencer LV, Burruss JB, Holtman J. Azathioprine: An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 1991; 127: 515-522.

Tsokos GC , Caughman SW , Klippel JH Successful treatment of generalized discoid skin lesions with azathioprine. Its use in a patient with systemic lupus erythematosus. Prog Dermatol 1974 ; 8: 5-9.

Ashinoff R. , Werth VP , Frank AG Jr. Resistant discoid lupus erythematosus of palms and soles: Successful treatment with azathioprine. J Am Acad Dermatol 1988; 19: 961—965.

Goldstein E. , Carey W. Discoid lupus erythematosus: Successful treatment with oral methotrexate. Arch Dermatol 1994 ; 130: 938-939.

Bottomley WW , Goodfield M. Methotrexate for the treatment of severe mucocutaneous lupus erythematosus. Br J Dermatol 1995 ; 133: 311-314.

Schulz EJ , Menter MA Treatment of discoid and subacute cutaneous lupus erythematosus with cyclophosphamide . Br J Dermatol 1971; 85: 60-65.

Yung RL , Richardson BC Cytarabine therapy for refractory cutaneous lupus. Arthritis Rheum 1995; 38: 1341-1343.

Heule F. , vanJoost T. , Beukers R. Cyclosporine in the treatment of lupus erythematosus. Arch Dermatol 1986; 122: 973-974.

Yell JA , Burge SM Cyclosporin and discoid lupus erythematosus. Br J Dermatol 1994; 131: 132-133.

Lernia VD , Bisighini G. Discoid lupus erythematosus during treatment with cyclosporine. Acta Derm Venereol 1996 ; 76: 87-88.

Piette J-C. et al. High-dose immunoglobulins in the treatment of refractory cutaneous lupus erythematosus. Open trial in 5 cases. Arthritis Rheum 1995; 38: S304 (abstract).

Coburn PR , Shuster S. Dapsone and discoid lupus erythematosus. Br J Dermatol 1982 ; 106: 105-106.

Lindskov R. , Reymann F. Dapsone in the treatment of cutaneous lupus erythematosus. Dermatologica 1986; 172: 214-217.

Ruzicka T. , Goerz G. Dapsone in the treatment of lupus erythematosus. Br J Dermatol 1981 ; 104: 53—56.

Jakes JT , Dubois EL , Quismorio FT Jr. Antileprosy drugs in the treatment of systemic (SLE) and discoid lupus erythematosus (discoid LE). Arthr Rheum 1982; 25: 580.

Hall RP et al. Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy. Ann Intern Med 1982; 97: 165-170.

Holtman J. , Neustadt D. , Callen JP Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency . J Rheumatol 1990; 17: 122—1225.

Krivanek Jfc et al. Clofazimine (Lamprene) in the treatment of discoid lupus erythematosus. Australasian J Dermatol 1976; 17: 108-110.

Krivanek Jfc , Paver Wka. Further study of the use of clofazimine in discoid lupus erythematosus. Australasian J Dermatol 1980; 21: 169-171.

Grosshans E. , Illy G. Thalidomide therapy for inflammatory dermatoses . Int J Dermatol 1984 ; 23: 598-602.

Atra E. , Sato EI Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide . Clin Exp Rheumatol 1993; 11: 487-493.

Ayres S. Jr, Mihan R. Lupus erythematosus and Vitamin E: an effective and non-toxic therapy. Cutis 1974; 23: 49-54.

Yell JA , Burge S. , Wojnarowska F. Vitamin E and discoid lupus erythematosus. Lupus 1992; 1: 303-305.

Dalziel K. et al. Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin). Br J Dermatol 1986 ; 115: 211-216.

Steinkjer B. Auranofin in the treatment of discoid lupus erythematosus. J Dermatol Treat 1991; 2: 27-29.

Rodriquez-Castellanos MA , Rubio JB , Gomez Jfb , Mendoza AG Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 1995; 131: 620-621.

Nicolas J-F. , Thivolet J. , Kanitkis J. , Lyonnet S. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 1990; 95: 142S-145S.

Tebbe B. , Lauy M. , Gollnick H. Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a: a case report. Eur J Dermatol 1992 ; 2: 2153-255.

Prinz JC et al. Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. JAm Acad Dermatol 1996; 34: 244-252.

Newton RC et al. Mechanism-oriented assessment of isotretinoin in chronic or subacute lupus erythematosus. Arch Dermatol 1986; 122: 180-176.

Furner BB Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 1990; 29: 587-590.

Ruzicka T. , Meurer M. , Brown-Falco O. Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol (Stockh) 1985; 65: 324-329.

Green LS et al. Clinical and immunologic features of livedo reticularis in lupus erythematosus: Successful therapy with etretinate. J Dermatol Treat 1989; 1: 19-22.